Clinical trial

BB-101 for Treatment of Diabetic Lower Leg and Foot Ulcers

NCT03888053

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-03-28

PhasePHASE1

Study timeline

Study start (actual)2018-03-28Date precision: day

Registry last updated2026-04-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Foot Ulcerunresolved

Interventions

BB-101BIOLOGICAL

Sponsors & collaborators

Blue Blood Biotech Corp.lead sponsor

Mapped research locations

TaipeiTaiwan2 Kaohsiung CityTaiwan2 TainanTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03888053 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.